Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Rigel Pharmaceuticals
Business Segments
Products & Services
Government contracts revenue
Government contracts revenue
Rigel Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Government Assistance Operating Income
Breakdown
Segments
fostamatinib
View metric
Watchlist
Screener
Filings
Earnings
Charts
Annual
Segment
FY'25
fostamatinib
$300K
Total
—
All segment values are derived from annual filings.